Request for Covid-19 Impact Assessment of this Report
The United States Basiliximab Injection market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Basiliximab Injection market, reaching US$ million by the year 2028. As for the Europe Basiliximab Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Basiliximab Injection players cover Novartis AG, Ryvis Pharma, , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Basiliximab Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
20 mL
10 mL
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Adult Use
Pediatric Use
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Novartis AG
Ryvis Pharma
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Basiliximab Injection Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Basiliximab Injection by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Basiliximab Injection by Country/Region, 2017, 2022 & 2028
2.2 Basiliximab Injection Segment by Type
2.2.1 20 mL
2.2.2 10 mL
2.3 Basiliximab Injection Sales by Type
2.3.1 Global Basiliximab Injection Sales Market Share by Type (2017-2022)
2.3.2 Global Basiliximab Injection Revenue and Market Share by Type (2017-2022)
2.3.3 Global Basiliximab Injection Sale Price by Type (2017-2022)
2.4 Basiliximab Injection Segment by Application
2.4.1 Adult Use
2.4.2 Pediatric Use
2.5 Basiliximab Injection Sales by Application
2.5.1 Global Basiliximab Injection Sale Market Share by Application (2017-2022)
2.5.2 Global Basiliximab Injection Revenue and Market Share by Application (2017-2022)
2.5.3 Global Basiliximab Injection Sale Price by Application (2017-2022)
3 Global Basiliximab Injection by Company
3.1 Global Basiliximab Injection Breakdown Data by Company
3.1.1 Global Basiliximab Injection Annual Sales by Company (2020-2022)
3.1.2 Global Basiliximab Injection Sales Market Share by Company (2020-2022)
3.2 Global Basiliximab Injection Annual Revenue by Company (2020-2022)
3.2.1 Global Basiliximab Injection Revenue by Company (2020-2022)
3.2.2 Global Basiliximab Injection Revenue Market Share by Company (2020-2022)
3.3 Global Basiliximab Injection Sale Price by Company
3.4 Key Manufacturers Basiliximab Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Basiliximab Injection Product Location Distribution
3.4.2 Players Basiliximab Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Basiliximab Injection by Geographic Region
4.1 World Historic Basiliximab Injection Market Size by Geographic Region (2017-2022)
4.1.1 Global Basiliximab Injection Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Basiliximab Injection Annual Revenue by Geographic Region
4.2 World Historic Basiliximab Injection Market Size by Country/Region (2017-2022)
4.2.1 Global Basiliximab Injection Annual Sales by Country/Region (2017-2022)
4.2.2 Global Basiliximab Injection Annual Revenue by Country/Region
4.3 Americas Basiliximab Injection Sales Growth
4.4 APAC Basiliximab Injection Sales Growth
4.5 Europe Basiliximab Injection Sales Growth
4.6 Middle East & Africa Basiliximab Injection Sales Growth
5 Americas
5.1 Americas Basiliximab Injection Sales by Country
5.1.1 Americas Basiliximab Injection Sales by Country (2017-2022)
5.1.2 Americas Basiliximab Injection Revenue by Country (2017-2022)
5.2 Americas Basiliximab Injection Sales by Type
5.3 Americas Basiliximab Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Basiliximab Injection Sales by Region
6.1.1 APAC Basiliximab Injection Sales by Region (2017-2022)
6.1.2 APAC Basiliximab Injection Revenue by Region (2017-2022)
6.2 APAC Basiliximab Injection Sales by Type
6.3 APAC Basiliximab Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Basiliximab Injection by Country
7.1.1 Europe Basiliximab Injection Sales by Country (2017-2022)
7.1.2 Europe Basiliximab Injection Revenue by Country (2017-2022)
7.2 Europe Basiliximab Injection Sales by Type
7.3 Europe Basiliximab Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Basiliximab Injection by Country
8.1.1 Middle East & Africa Basiliximab Injection Sales by Country (2017-2022)
8.1.2 Middle East & Africa Basiliximab Injection Revenue by Country (2017-2022)
8.2 Middle East & Africa Basiliximab Injection Sales by Type
8.3 Middle East & Africa Basiliximab Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Basiliximab Injection
10.3 Manufacturing Process Analysis of Basiliximab Injection
10.4 Industry Chain Structure of Basiliximab Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Basiliximab Injection Distributors
11.3 Basiliximab Injection Customer
12 World Forecast Review for Basiliximab Injection by Geographic Region
12.1 Global Basiliximab Injection Market Size Forecast by Region
12.1.1 Global Basiliximab Injection Forecast by Region (2023-2028)
12.1.2 Global Basiliximab Injection Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Basiliximab Injection Forecast by Type
12.7 Global Basiliximab Injection Forecast by Application
13 Key Players Analysis
13.1 Novartis AG
13.1.1 Novartis AG Company Information
13.1.2 Novartis AG Basiliximab Injection Product Offered
13.1.3 Novartis AG Basiliximab Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Novartis AG Main Business Overview
13.1.5 Novartis AG Latest Developments
14 Research Findings and Conclusion
Table 1. Basiliximab Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Basiliximab Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 20 mL
Table 4. Major Players of 10 mL
Table 5. Global Basiliximab Injection Sales by Type (2017-2022) & (KL)
Table 6. Global Basiliximab Injection Sales Market Share by Type (2017-2022)
Table 7. Global Basiliximab Injection Revenue by Type (2017-2022) & ($ million)
Table 8. Global Basiliximab Injection Revenue Market Share by Type (2017-2022)
Table 9. Global Basiliximab Injection Sale Price by Type (2017-2022) & (US$/L)
Table 10. Global Basiliximab Injection Sales by Application (2017-2022) & (KL)
Table 11. Global Basiliximab Injection Sales Market Share by Application (2017-2022)
Table 12. Global Basiliximab Injection Revenue by Application (2017-2022)
Table 13. Global Basiliximab Injection Revenue Market Share by Application (2017-2022)
Table 14. Global Basiliximab Injection Sale Price by Application (2017-2022) & (US$/L)
Table 15. Global Basiliximab Injection Sales by Company (2020-2022) & (KL)
Table 16. Global Basiliximab Injection Sales Market Share by Company (2020-2022)
Table 17. Global Basiliximab Injection Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Basiliximab Injection Revenue Market Share by Company (2020-2022)
Table 19. Global Basiliximab Injection Sale Price by Company (2020-2022) & (US$/L)
Table 20. Key Manufacturers Basiliximab Injection Producing Area Distribution and Sales Area
Table 21. Players Basiliximab Injection Products Offered
Table 22. Basiliximab Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Basiliximab Injection Sales by Geographic Region (2017-2022) & (KL)
Table 26. Global Basiliximab Injection Sales Market Share Geographic Region (2017-2022)
Table 27. Global Basiliximab Injection Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Basiliximab Injection Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Basiliximab Injection Sales by Country/Region (2017-2022) & (KL)
Table 30. Global Basiliximab Injection Sales Market Share by Country/Region (2017-2022)
Table 31. Global Basiliximab Injection Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Basiliximab Injection Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Basiliximab Injection Sales by Country (2017-2022) & (KL)
Table 34. Americas Basiliximab Injection Sales Market Share by Country (2017-2022)
Table 35. Americas Basiliximab Injection Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Basiliximab Injection Revenue Market Share by Country (2017-2022)
Table 37. Americas Basiliximab Injection Sales by Type (2017-2022) & (KL)
Table 38. Americas Basiliximab Injection Sales Market Share by Type (2017-2022)
Table 39. Americas Basiliximab Injection Sales by Application (2017-2022) & (KL)
Table 40. Americas Basiliximab Injection Sales Market Share by Application (2017-2022)
Table 41. APAC Basiliximab Injection Sales by Region (2017-2022) & (KL)
Table 42. APAC Basiliximab Injection Sales Market Share by Region (2017-2022)
Table 43. APAC Basiliximab Injection Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Basiliximab Injection Revenue Market Share by Region (2017-2022)
Table 45. APAC Basiliximab Injection Sales by Type (2017-2022) & (KL)
Table 46. APAC Basiliximab Injection Sales Market Share by Type (2017-2022)
Table 47. APAC Basiliximab Injection Sales by Application (2017-2022) & (KL)
Table 48. APAC Basiliximab Injection Sales Market Share by Application (2017-2022)
Table 49. Europe Basiliximab Injection Sales by Country (2017-2022) & (KL)
Table 50. Europe Basiliximab Injection Sales Market Share by Country (2017-2022)
Table 51. Europe Basiliximab Injection Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Basiliximab Injection Revenue Market Share by Country (2017-2022)
Table 53. Europe Basiliximab Injection Sales by Type (2017-2022) & (KL)
Table 54. Europe Basiliximab Injection Sales Market Share by Type (2017-2022)
Table 55. Europe Basiliximab Injection Sales by Application (2017-2022) & (KL)
Table 56. Europe Basiliximab Injection Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Basiliximab Injection Sales by Country (2017-2022) & (KL)
Table 58. Middle East & Africa Basiliximab Injection Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Basiliximab Injection Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Basiliximab Injection Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Basiliximab Injection Sales by Type (2017-2022) & (KL)
Table 62. Middle East & Africa Basiliximab Injection Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Basiliximab Injection Sales by Application (2017-2022) & (KL)
Table 64. Middle East & Africa Basiliximab Injection Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Basiliximab Injection
Table 66. Key Market Challenges & Risks of Basiliximab Injection
Table 67. Key Industry Trends of Basiliximab Injection
Table 68. Basiliximab Injection Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Basiliximab Injection Distributors List
Table 71. Basiliximab Injection Customer List
Table 72. Global Basiliximab Injection Sales Forecast by Region (2023-2028) & (KL)
Table 73. Global Basiliximab Injection Sales Market Forecast by Region
Table 74. Global Basiliximab Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Basiliximab Injection Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Basiliximab Injection Sales Forecast by Country (2023-2028) & (KL)
Table 77. Americas Basiliximab Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Basiliximab Injection Sales Forecast by Region (2023-2028) & (KL)
Table 79. APAC Basiliximab Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Basiliximab Injection Sales Forecast by Country (2023-2028) & (KL)
Table 81. Europe Basiliximab Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Basiliximab Injection Sales Forecast by Country (2023-2028) & (KL)
Table 83. Middle East & Africa Basiliximab Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Basiliximab Injection Sales Forecast by Type (2023-2028) & (KL)
Table 85. Global Basiliximab Injection Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Basiliximab Injection Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Basiliximab Injection Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Basiliximab Injection Sales Forecast by Application (2023-2028) & (KL)
Table 89. Global Basiliximab Injection Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Basiliximab Injection Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Basiliximab Injection Revenue Market Share Forecast by Application (2023-2028)
Table 92. Novartis AG Basic Information, Basiliximab Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Novartis AG Basiliximab Injection Product Offered
Table 94. Novartis AG Basiliximab Injection Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 95. Novartis AG Main Business
Table 96. Novartis AG Latest Developments
Table 97. Ryvis Pharma Basic Information, Basiliximab Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Ryvis Pharma Basiliximab Injection Product Offered
Table 99. Ryvis Pharma Basiliximab Injection Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 100. Ryvis Pharma Main Business
Table 101. Ryvis Pharma Latest Developments
List of Figures
Figure 1. Picture of Basiliximab Injection
Figure 2. Basiliximab Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Basiliximab Injection Sales Growth Rate 2017-2028 (KL)
Figure 7. Global Basiliximab Injection Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Basiliximab Injection Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 20 mL
Figure 10. Product Picture of 10 mL
Figure 11. Global Basiliximab Injection Sales Market Share by Type in 2021
Figure 12. Global Basiliximab Injection Revenue Market Share by Type (2017-2022)
Figure 13. Basiliximab Injection Consumed in Adult Use
Figure 14. Global Basiliximab Injection Market: Adult Use (2017-2022) & (KL)
Figure 15. Basiliximab Injection Consumed in Pediatric Use
Figure 16. Global Basiliximab Injection Market: Pediatric Use (2017-2022) & (KL)
Figure 17. Global Basiliximab Injection Sales Market Share by Application (2017-2022)
Figure 18. Global Basiliximab Injection Revenue Market Share by Application in 2021
Figure 19. Basiliximab Injection Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Basiliximab Injection Revenue Market Share by Company in 2021
Figure 21. Global Basiliximab Injection Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Basiliximab Injection Revenue Market Share by Geographic Region in 2021
Figure 23. Global Basiliximab Injection Sales Market Share by Region (2017-2022)
Figure 24. Global Basiliximab Injection Revenue Market Share by Country/Region in 2021
Figure 25. Americas Basiliximab Injection Sales 2017-2022 (KL)
Figure 26. Americas Basiliximab Injection Revenue 2017-2022 ($ Millions)
Figure 27. APAC Basiliximab Injection Sales 2017-2022 (KL)
Figure 28. APAC Basiliximab Injection Revenue 2017-2022 ($ Millions)
Figure 29. Europe Basiliximab Injection Sales 2017-2022 (KL)
Figure 30. Europe Basiliximab Injection Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Basiliximab Injection Sales 2017-2022 (KL)
Figure 32. Middle East & Africa Basiliximab Injection Revenue 2017-2022 ($ Millions)
Figure 33. Americas Basiliximab Injection Sales Market Share by Country in 2021
Figure 34. Americas Basiliximab Injection Revenue Market Share by Country in 2021
Figure 35. United States Basiliximab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Basiliximab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Basiliximab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Basiliximab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Basiliximab Injection Sales Market Share by Region in 2021
Figure 40. APAC Basiliximab Injection Revenue Market Share by Regions in 2021
Figure 41. China Basiliximab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Basiliximab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Basiliximab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Basiliximab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Basiliximab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Basiliximab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Basiliximab Injection Sales Market Share by Country in 2021
Figure 48. Europe Basiliximab Injection Revenue Market Share by Country in 2021
Figure 49. Germany Basiliximab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Basiliximab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Basiliximab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Basiliximab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Basiliximab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Basiliximab Injection Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Basiliximab Injection Revenue Market Share by Country in 2021
Figure 56. Egypt Basiliximab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Basiliximab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Basiliximab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Basiliximab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Basiliximab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Basiliximab Injection in 2021
Figure 62. Manufacturing Process Analysis of Basiliximab Injection
Figure 63. Industry Chain Structure of Basiliximab Injection
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...